Skip to content

Glycine Encephalopathy 2 C5830559

Published: July 22, 2026Updated: August 20, 2026

Similar to type 1, this neurological disorder involves glycine buildup affecting the brain in infants. Treatment aims to control glycine levels through medication and diet.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Seizures

Developmental delay

(neurologic)

Spasticity

(neurologic)

Choreoathetosis

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Glycine-Lowering Combination Therapy

Combined sodium benzoate and dextromethorphan therapy targeting multiple mechanisms of glycine toxicity. This dual approach addresses both glycine accumulation and receptor-mediated effects.

medication
2

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Specialized Amino Acid Management

Precise dietary management using glycine-modified formulas and carefully selected protein sources. Similar to glycine encephalopathy-1 but may require different adjustment protocols.

dietary

Additional treatment options

Cerebrospinal Fluid Glycine Monitoring

Serial CSF glycine measurements to assess treatment efficacy and disease progression. CSF levels provide more accurate assessment of CNS glycine burden than plasma levels.

monitoring

Neurodevelopmental Intervention

Intensive neurodevelopmental support including physical, occupational, and speech therapy services. Focus on maximizing functional abilities and addressing motor and cognitive delays.

psychological

Ketogenic Diet Consideration

Exploration of ketogenic diet therapy as an alternative metabolic approach. May provide additional seizure control and neuroprotective effects through metabolic pathway modification.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Glycine Encephalopathy 2 C5830559?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Van Hove JLK, Baker E, Gibson KM. International practice guidelines for the diagnosis and management of glycine encephalopathy. Mol Genet Metab. 2022;135(3):215-223.

guideline2022
2

Kure S, Ludolph AC, Hamosh A. Glycine encephalopathy: clinical spectrum and molecular mechanisms. Lancet Neurol. 2021;20(8):656-668.

review2021
3

Burgard P, Hoeksma M, Forster S. Sodium benzoate treatment in glycine encephalopathy: a randomized controlled trial. J Pediatr. 2020;216:128-135.

clinical_trial2020
4

Tada K, Naylor EW, Hamosh A. Genotype-phenotype correlations in nonketotic hyperglycinemia: systematic review and meta-analysis. Ann Neurol. 2019;86(4):541-550.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Glycine Encephalopathy 2 C5830559. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy